Your browser doesn't support javascript.
loading
Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.
Klein, Oliver; Senko, Clare; Carlino, Matteo S; Markman, Ben; Jackett, Louise; Gao, Bo; Lum, Caroline; Kee, Damien; Behren, Andreas; Palmer, Jodie; Cebon, Jonathan.
Afiliação
  • Klein O; Department of Medical Oncology, Austin Health, Melbourne, Australia.
  • Senko C; Olivia Newton-John Cancer Research Institute, Melbourne, Australia.
  • Carlino MS; Department of Medical Oncology, Austin Health, Melbourne, Australia.
  • Markman B; Blacktown Hospital and the University of Sydney, Sydney, Australia.
  • Jackett L; Department of Medical Oncology, Alfred Health, Melbourne Australia.
  • Gao B; School of Clinical Sciences, Monash University, Melbourne, Australia.
  • Lum C; Department of Anatomical Pathology, Austin Health, Melbourne Australia.
  • Kee D; Blacktown Hospital and the University of Sydney, Sydney, Australia.
  • Behren A; Department of Medical Oncology, Monash Health, Melbourne, Australia.
  • Palmer J; Department of Medical Oncology, Austin Health, Melbourne, Australia.
  • Cebon J; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Oncoimmunology ; 10(1): 1908771, 2021 04 12.
Article em En | MEDLINE | ID: mdl-33889439
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália